Work

Post-marketing safety surveillance of Amivantamab: a real world study based on the FDA adverse event reporting system

Year: 2025

Type: article

Study design: Observational Study

Source: Expert Opinion on Drug Safety

DOI: 10.1080/14740338.2025.2471512

Authors: Xiang Fu, Dongqiang Zeng, Min Li, Jianhua Wu, Jianhua Wu, Yufan Yang, Qianqian Mao, Wenjun Qiu, Xiatong Huang, Yiran Fang, Luyang Jiang, Panwei Hu, Jiani Wu, Jiani Wu, Wangjun Liao

Institutions: Southern Medical University, South China University of Technology, Shanghai University of Traditional Chinese Medicine, Shuguang Hospital

Language: English

Topic: Pharmacovigilance and Adverse Drug Reactions

Subfield: Toxicology

Field: Pharmacology, Toxicology and Pharmaceutics

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: China Postdoctoral Science Foundation

Award: G7951223286

OpenAlex ID: W4407958232

FWCI: 2.672

Cites: 30

Cited by: 2

Related to: 10